Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Major biotechs weather storm in 2002. (Markets: Life Sciences).(Industry Overview)
- FOR THE MAJOR US biotechnology companies, analysts see 2002 as a transition to improved earnings in 2003, with several companies seeking to move beyond capacity shortfalls, inventory overhang or lackluster clinical trial results and product delays. FOR THE MAJOR US biotechnology companies, analysts see...
- Research articles 2002-12-02
- Biotechnology Conference Announced: Silicon Alley Entrepreneurs Club to Host Biotech and Life Sciences Global Venture Congress™ 2005 at Madison Square Garden; Nobel Laureate Dr. Eric Chivian Will Address The Plenary Session
- NEW YORK -- Silicon Alley Entrepreneurs Club SAEC, NY will host its Global Venture CongressTM Series on Biotech and Life Sciences at Madison Square Garden, New York (http://bio.saeclub.com) Aug. 25-26, 2005.
- Research articles 2005-06-29
- Life Sciences and Biotechnology - the European Commission's Strategy for Europe.
- Originally published June 2004 Originally published June 2004
- Research articles 2004-06-29
- SonoSite to Present at Two Investor Conferences In September — Northwest Medical Device & Biotechnology Forum and UBS Global Life Sciences Conference
- BOTHELL, Wash. -- SonoSite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced that Mike Schuh, Chief Financial Officer, and Anne Bugge, Vice President of Corporate Affairs, will present at the Northwest Medical Device & Biotechnology Investor Forum at 10:00 a.m. ET on Tuesday, September 20, 2005, at the...
- Research articles 2005-09-14
- EPA Panel Drafts New Testing Requirements for Biotech Crops.
- LIFE SCIENCE companies developing genetically modified crops may be required to conduct an array of new tests to detect any harmful effects for mallard ducks, rainbow trout, honeybees, and other wildlife, say scientists. An Environmental Prot LIFE SCIENCE...
- Research articles 1999-12-20
- Nektar to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medtech Conference, Oppenheimer Diabetes Conference and UBS Investment Bank 2006 Global Life Sciences Conference
- SAN CARLOS, Calif. -- Nektar Therapeutics (Nasdaq:NKTR) will be presenting at the Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference in London, on Thursday, September 21 at 11:20am UK Time. Chris Searcy, vice president of corporate development, will be presenting the corporate overview at Merrill Lynch. John Patton, co-founder and...
- Research articles 2006-09-11
- Engineering and Life Sciences Converging.
- The fields of engineering and the life sciences are converging to create an essential multidisciplinary framework for the anticipated discoveries and product innovations in biotechnology, according to a study by ASME International (American Society of Mec The fields of engineering and the life sciences are...
- Research articles 2002-08-01
- Silicon Alley Entrepreneurs Club Announces Biotech and Life Sciences Global Venture Congress 2004 at Madison Square Garden in New York City
- NEW YORK -- Legendary Nobel Laureate James Watson Is Keynote Speaker
- Research articles 2004-10-21
- Michigan has the potential to become a biotech powerhouse, but for a state built on manufacturing, the task of developing that potential has been described as "Like playing chess with no squares": Part 1 of 2.
- Byline: Andrew Dietderich When entrepreneurs and scientists working in life sciences step off the plane in Detroit, Randal Charlton said they should be greeted by a large welcoming party. For starters, the chairman of Ann Arbor-based MichBio sai Byline: Andrew Dietderich...
- Research articles 2006-06-05
- Active Biotech to Present at the UBS 2007 Global Life Sciences Conference
- Active Biotech (OMX Nordic: ACTI) management is scheduled to present at the UBS Global Life Sciences Conference on Wednesday, September 26 at the Grand Hyatt Hotel in New York City, US. During the presentation, management will provide an update on the Active Biotech development programs.
- Research articles 2007-09-20
- Pfizer: Crisis or opportunity? As Ann Arbor regroups, some see hope amid the bad news.
- Byline: Andrew Dietderich Scan last week's headlines in Southeast Michigan and it might be hard to see any hope for life sciences or biotech here. But Stephen Rapundalo says that in five years the decision by Pfizer Inc. to close its Ann Arbor cam...
- Research articles 2007-01-29
- C3i-Sponsored Conference on CRM for the Pharmaceutical Industry Focuses on Hot Issues, Attracting Leaders in the Life Sciences, Biotechnology, and CRM Industries
- Health/Medical Writers
- Research articles 2000-09-12
- Burrill & Company - A Life Sciences Merchant Bank
- This paper focuses on Biotech industry.Burrill & Company is a life sciences merchant bank, focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, human healthcare and related medical technologies, wellness and nutraceuticals, agricultural technologies, and industrial biotechnology. Burrill & Company assists life science companies in identifying, negotiating and closing strategic...
- White papers 2004-06-09
- Life Sciences: New 'Bubble' or Sunrise Sector?
- The slump in technology markets has left other sectors with a chance to move onto the investment radar. In this article, Nabarro Nathanson, describes how with enormous advances in biotechnology, particularly the Human Genome Programme, the life sciences industry is now back in vogue, as investors are looking for longer-term...
- White papers 2002-06-19
- Towards a Strategic Vision of Life Sciences and Biotechnology: Consultation Document
- Life sciences and technology are of strategic importance if Europe is to stay a leading knowledge-based economy. In this paper the European Commission discusses the wide range of questions, that need to be addressed in this sector, and the complexity of issues attached to it is explained. The other main...
- White papers 2001-04-09
- Life Sciences Still Attracting VC Investment
- In the wake of the dotcom fallout, however, venture investors' injections of money to life sciences companies are quite healthy. First time financings of new biotechnology companies in the second quarter of 2002, for instance, surpassed similar investments in telecommunications and software. New biotech investments rose to $296 million in...
- White papers 2002-09-18
- MassBiotech 2010: Achieving Global Leadership in the Life-Sciences Economy
- After decades of innovation and investment, the Massachusetts biotechnology industry is poised on the threshold of a new era of growth. It is far from clear, however, whether it is going to capture the full benefits. Competition for biotech jobs from other states is getting tougher. This report analyzes the...
- White papers 2002-11-21
- Verity PharmaCI: Using Information to Stay Ahead of the Competition in Life Sciences
- Pharmaceutical and biotechnology companies are under pressure to bring drugs to market quicker. Thus there is a need to maximize their return on each new drug introduced to the market, to comply with stringent government regulations, to understand the impact of patent expiration on their drug portfolio and to rapidly...
- White papers 2005-06-29
- STARLIMS Technologies Ltd. Q2 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. The first question comes from Maureen Drew from Gagnon Securities. Please state your question. Maureen Drew - Gagnon Securities I have a few questions. Financial income in the quarter looks a little outsized, was there something special there? Chaim Friedman That included about 650,000 out...
- Earnings calls 2009-08-18
- In the Spotlight: Kellogg Center for Biotechnology Management
- When the market speaks, Kellogg School of Management listens. Recruiters began clamoring for a program addressing the commercialization of life sciences -- pharmaceutical, biotech, medical devices and agriculture -- back in 2000, so Kellogg went to work creating the Center for Biotechnology to study innovations in this area and to...
- Blog posts 2008-12-04
- << Previous
- page 1 of 2
- Next >>
Presented by American Express